. Author manuscript; available in PMC: 2010 Jan 1.

Published in final edited form as: Osteoarthritis Cartilage. 2008 Jun 20;17(1):114–123. doi: 10.1016/j.joca.2008.05.006

Table 1.

Properties of constructs treated with BMP-2 in phase I.

Group	WW (mg)	Thickness (mm)	Total Cells (×10⁶)	FI
Control	21.8±2.4	0.67±0.04	4.6±0.5	0.75±0.18
100 ng/ml Continuous	23.7±1.8	0.71±0.07	5.3±0.3	0.94±0.06^a
100 ng/ml Wk Rotat.	22.6±1.9	0.71±0.04	4.8±0.9	0.96±0.08^a
10 ng/ml Continuous	23.3±2.0	0.73±0.07	4.4±1.0	0.97±0.10^a
10 ng/ml Wk Rotat.	23.8±1.3	0.72±0.04	4.8±0.3	0.92±0.06^a

Significantly different from control

Wk Rotat., 2-wk rotation dosage; Col., total collagen